M
Est. 1997. Life sciences VC fund managing c.£560m+ AUM across 4-6 funds. Portfolio incl. Heptares, Domantis, Cara Therapeutics, CurvaFix, Wilson Therapeutics. 25+ yrs healthcare VC experience. Offices Boston, London, San Francisco Bay. 30 team members. Co-founder: Dr Stephen Reeders.
Check Size
£11.5M - £24M
Investment Focus
Investment Thesis
Differentiated therapeutics, medical devices, diagnostics, digital health, contract manufacturing. Early to late-stage, $15-30m typical tickets. UK/US focus. Target unmet medical needs, IP-protected technologies, durable competitive advantages. Avoid unfocused biotech, early seed. Value-add: mgmt guidance, strategic M&A support, transatlantic network leverage.
Interested in connecting?
Visit their website or reach out directly.